Company Profile
Arcturus Therapeutics Holdings Inc. Stock Price, News & Analysis
- Ticker:
- ARCT
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Arcturus Therapeutics Holdings is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Stock performance
7.08 USD (-2.07%)
Close
Last updated: June 23, 2026 at 00:00
201.24M USD
Market cap
Why the stock is moving
ARCT is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Arcturus Therapeutics Holdings is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Arcturus Therapeutics Holdings is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Arcturus Therapeutics Holdings follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Arcturus Therapeutics Holdings sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Arcturus Therapeutics Holdings Inc. (ARCT)?
Arcturus Therapeutics Holdings Inc. (ARCT) most recently closed at 7.08 USD, a -2.07% move versus the previous session.
What is the market cap of Arcturus Therapeutics Holdings Inc. (ARCT)?
Arcturus Therapeutics Holdings Inc. currently has a market capitalization of 201.24M USD on BioPharmSignal.
What does Arcturus Therapeutics Holdings Inc. do?
Arcturus Therapeutics Holdings is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
On which exchange is ARCT stock listed?
Arcturus Therapeutics Holdings Inc. (ARCT) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Arcturus Therapeutics Holdings is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts., Biotechnology.
What is Arcturus?
Arcturus Therapeutics Holdings is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Which conditions is Arcturus Therapeutics Holdings Inc. targeting with Arcturus?
Arcturus Therapeutics Holdings is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
What is Therapeutics?
Arcturus Therapeutics Holdings is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
What is Holdings?
Arcturus Therapeutics Holdings is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.